Disease perception, quality of life and mental health among Chinese patients with transplant-eligible newly diagnosed multiple myeloma following treatment: a cross-sectional survey study

Aim: This study evaluated disease perception, health-related quality of life (HRQoL) and mental health among Chinese patients with transplant-eligible newly diagnosed multiple myeloma (NDMM) after treatment in Chinese tertiary hospital settings. Materials & methods: This cross-sectional survey enrolled patients after the treatments for NDMM in two Chinese tertiary hospitals between January and June 2025. This survey study collected disease perception, HRQoL assessment using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) instrument and psychological assessment using the 9-item Patient Health Questionnaire (PHQ-9) for depression and the 7-item Generalized Anxiety Disorder scale (GAD-7) for anxiety. Patients were categorized according to treatment pathway (autologous stem cell transplantation [ASCT] vs non-ASCT) for exploratory descriptive comparisons. Multivariable regression analyses were used to explore any factors associated with HRQoL and psychological outcomes. Results: The cohort had a mean age of 57.2 years; 39.6% were male. Pathological fractures (54.7%) and hypertension (35.8%) were common in these surveyed patients. Knowledge gaps existed regarding the negative impact of MM on renal impairment and anemia. The mean EQ-5D utility score was 0.849; anemia was negatively associated with EQ-5D utility score (coefficient, -0.253; 95% CI: -0.444 to -0.062; p = 0.011). Regarding psychological outcomes, the mean GAD-7 anxiety score and PHQ-9 depression score were 4.7 and 3.1, respectively. Progressive disease was significantly associated with higher anxiety (GAD-7: coefficient, 7.963; 95% CI: 3.804 to 12.122; p < 0.001) and depression (PHQ-9: coefficient, 3.358; 95% CI: 1.091 to 5.624; p = 0.005). Conclusion: HRQoL was generally preserved in treated Chinese patients with NDMM, but anemia was linked to poorer HRQoL and progressive disease to greater anxiety and depression, supporting targeted education and psychosocial care.

Authors

Institutions

Publication Details

Journal
Journal of Comparative Effectiveness Research
Published
2026-11-11
DOI
https://doi.org/10.57264/cer-2026-0155
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Disease perception, quality of life and mental health among Chinese patients with transplant-eligible newly diagnosed multiple myeloma following treatment: a cross-sectional survey study

Wendong Chen, Jianbo Meng, Chunjia Chen, Guru Sharan Sah et al.
Journal of Comparative Effectiveness Research
Multiple Myeloma Research and Treatments
article

Disease perception, quality of life and mental health among Chinese patients with transplant-eligible newly diagnosed multiple myeloma following treatment: a cross-sectional survey study

Wendong Chen, Jianbo Meng, Chunjia Chen, Guru Sharan Sah, Jiayi Wang, Jiawen You, Yuan Meng, Xiaojun Liu, Yiming Zhao, Yuanyuan Zhang, Haijun Sun
article en

Abstract

Aim: This study evaluated disease perception, health-related quality of life (HRQoL) and mental health among Chinese patients with transplant-eligible newly diagnosed multiple myeloma (NDMM) after treatment in Chinese tertiary hospital settings. Materials & methods: This cross-sectional survey enrolled patients after the treatments for NDMM in two Chinese tertiary hospitals between January and June 2025. This survey study collected disease perception, HRQoL assessment using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) instrument and psychological assessment using the 9-item Patient Health Questionnaire (PHQ-9) for depression and the 7-item Generalized Anxiety Disorder scale (GAD-7) for anxiety. Patients were categorized according to treatment pathway (autologous stem cell transplantation [ASCT] vs non-ASCT) for exploratory descriptive comparisons. Multivariable regression analyses were used to explore any factors associated with HRQoL and psychological outcomes. Results: The cohort had a mean age of 57.2 years; 39.6% were male. Pathological fractures (54.7%) and hypertension (35.8%) were common in these surveyed patients. Knowledge gaps existed regarding the negative impact of MM on renal impairment and anemia. The mean EQ-5D utility score was 0.849; anemia was negatively associated with EQ-5D utility score (coefficient, -0.253; 95% CI: -0.444 to -0.062; p = 0.011). Regarding psychological outcomes, the mean GAD-7 anxiety score and PHQ-9 depression score were 4.7 and 3.1, respectively. Progressive disease was significantly associated with higher anxiety (GAD-7: coefficient, 7.963; 95% CI: 3.804 to 12.122; p < 0.001) and depression (PHQ-9: coefficient, 3.358; 95% CI: 1.091 to 5.624; p = 0.005). Conclusion: HRQoL was generally preserved in treated Chinese patients with NDMM, but anemia was linked to poorer HRQoL and progressive disease to greater anxiety and depression, supporting targeted education and psychosocial care.

Journal of Comparative Effectiveness Research
Hebei Medical University (CN), Third Hospital of Hebei Medical University (CN), Second Hospital of Hebei Medical University (CN), B.P. Koirala Memorial Cancer Hospital (NP)
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon